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PanicA reduction of dopamine release or D2 receptor blockade in the terminal ﬁelds of the mesolimbic
system, particularly the amygdala, clearly reduces conditioned fear. Similar D2 receptor antagonism
in the neural substrates of fear in the midbrain tectum attenuates the processing of unconditioned
aversive information. However, the implications of the interplay between opposing actions of dopa-
mine in the rostral and caudal segments of the dopaminergic system are still unclear. Previous stud-
ies from this laboratory have reported the effects of dopaminergic drugs on behavior in rats in the
elevated plus maze, auditory-evoked potentials (AEPs) recorded from the midbrain tectum, fear-po-
tentiated startle, and conditioned freezing. These ﬁndings led to an interesting framework on the
functional roles of dopamine in both anxiety and fear states. Dopamine D2 receptor inhibition in
the terminal ﬁelds of the mesolimbic dopamine system generally causes anxiolytic-like effects,
whereas the activity of midbrain substrates of unconditioned fear are enhanced by D2 receptor
antagonists, suggesting that D2 receptor-mediated mechanisms play opposing roles in fear/anxiety
processes, depending on the brain region under study. Dopamine appears to mediate conditioned
fear by acting at rostral levels of the brain and regulate unconditioned fear at the midbrain level,
likely by reducing the sensorimotor gating of aversive events.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Background
Aversive stimuli that underlie aversive or stressful situations
can be divided into two categories: unconditioned and conditioned
stressors. Unconditioned aversive stimuli, such as pain, asphyxia,
and innate fear-inducing stimuli (e.g., snakes and tigers),
evoke unconditioned reﬂexive freezing and escape responses.
Conditioned aversive stimuli are neutral stimuli that have acquired
aversive properties because they have been previously paired with
a noxious or aversive event. A third category, general stressors, can
also be included as stimuli of an aversive nature that activate the
general alertness system. The latter has been represented by theactivating reticular ascending system, and different brain struc-
tures subserve each of the defense reactions that are triggered by
unconditioned and conditioned stressors [17,28,8,6,7].
When applied to periventricular structures, such as the dorsal
periaqueductal gray (dPAG) and medial hypothalamus, electrical
stimulation is well known to elicit escape behavior [5]. An impor-
tant step toward understanding the processes and mechanisms
that underlie this defensive response was the demonstration that
such periventricular stimulation induced an aversive effect.
Animals that received such stimulation readily learned to switch
off the stimulation whenever it was given the opportunity to do
so [43]. In the mid 1980s, the superior colliculus and inferior col-
liculus (IC) in the mesencephalon were also shown to be part of
this system, which has since been known as the encephalic aver-
sion system (EAS; [11,10,2]. From this time onward, substantial
evidence has been obtained to support the notion that defense
reactions that are elaborated at the level of the EAS are mediated
by multiple mechanisms (Fig. 1). Indeed, c-aminobutyric acid
(GABA), excitatory amino acid, neuropeptide (e.g., neurokinin),
opioid, and serotonin systems are now known to act together to
neurochemically mediate the neural substrates of aversion in this
Fig. 1. Schematic diagram that shows the various neurotransmitters that are known to mediate (") or regulate ð>Þ defensive behavior in the midbrain tectum, medial
hypothalamus, and amygdala, structures that belong to the encephalic aversion system (EAS). EAA, excitatory amino acids; GABA, c-aminobutyric acid; BZD, benzodiazepine;
5-HT, 5-hydroxytryptamine (serotonin); NO, nitric oxide.
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phins also play a role in mediating the EAS [4,37,38]. An excellent
review that was published at the beginning of this century pro-
posed that dopamine can also function as a mediator of condi-
tioned fear in terminal areas of the mesocorticolimbic system [33].
2. Dopamine in conditioned fear
In parallel with studies on the function of the EAS, the last two
decades also witnessed a large number of studies that sought to
elucidate the neural substrates that elaborate behaviors related
to the rewarding and pleasurable effects of stimulating certain
brain areas, such as the ventral tegmental area (VTA), nucleus
accumbens, and other rostral brain areas [16]. Many of these stud-
ies reported the essential involvement of long ascending ﬁber sys-
tems (e.g., dopaminergic ﬁbers). Today, this system is referred to as
the reward system. A turning point in the role of dopamine in the
modulation of brain function was the postulation that dopaminer-
gic systems that arise from the VTA mediate conditioned fear
responses. In fact, many studies have reported the involvement
of dopamine in aversive conditioning using diverse conditioned
fear paradigms, such as the contextual fear test, fear-potentiated
startle with the use of a context or light as conditioned stimuli,
and the two-way active avoidance test [39]; for review, see [33].
Despite the widely accepted notion that dopamine is involved
in the regulation of anxiety, no agreement has been reached on
whether dopamine enhances or diminishes anxiety. The former
hypothesis is largely based on earlier experiments in which the
effects of drugs that non-selectively act on brain dopamine sys-
tems were measured in animals that were subjected to tests of fear
conditioning [3,34,40,41,46,31,1,23]. With regard to dopamine’s
mediation of conditioned fear, an increase in dopamine metabo-
lism in the mesolimbic system is correlated with conditioned fear,
and a decrease in dopamine activity in the basolateral amygdala
(BLA) reduces the expression of conditioned fear [18,19,20]. In fact,
intraperitoneal injections of low doses of the D2 receptor agonist
quinpirole act at autoreceptors on VTA neurons, slowing dopamine
release at their terminals and causing a reduction of conditioned
fear responses [23,21]. Therefore, the fear response to a light (con-
ditioned stimulus [CS]) appeared to depend on the activation of
mesolimbic dopaminergic connections and could be speciﬁcallymodulated by manipulating these projection neurons. One
possibility that cannot be discarded is that the pathway that con-
nects the VTA with the amygdala promotes resistance to the aver-
sive effects of unconditioned stimuli (USs), suggesting that the
interplay between neural systems that are responsible for process-
ing conditioned and unconditioned fear stimuli may exist at this
level.
3. Dopamine in unconditioned fear
The EAS consists of the dorsal periaqueductal gray (dPAG),
superior and inferior colliculi, and the hypothalamus and is
responsible for the elaboration and expression of defense reactions
to unconditioned or innate aversive stimuli. The behavioral and
autonomic changes that are associated with defense reactions are
likely to be expressed as an aversive emotional-motivational state.
Activation of the dPAG motivates switch-off behavior, inhibits
antecedent behavior, facilitates escape from electric footshock,
and acts as an aversive US in Pavlovian conditioning and place
aversion procedures [17,28,6,7]. Considering that conditioned and
unconditioned fear may somehow overlap, one unresolved issue
remains. Substantial experimental evidence implicates the meso-
corticolimbic dopamine system in anxiety, but the functional role
of dopamine in the midbrain tectum associated with fear is still
unclear. Some reports associated dopamine in the midbrain tectum
with prepulse inhibition, catalepsy, and the modulation of auditory
signals from the IC to medial geniculate thalamus [42,32,44,27].
We present evidence that dopamine modulates the neural sub-
strates of fear in the EAS.
Unclear is the role of dopamine in unconditioned fear, particu-
larly in the EAS. No study approached this issue until 2004, when a
study conducted in our laboratory showed that dopamine facili-
tated unconditioned responses in rats in the light switch-off test
[36]. One year later, another study showed that systemic
administration of the selective dopamine D2 receptor antagonist
sulpiride caused proaversive effects in rats in the elevated plus
maze [26].
Given that the EAS does not function only as an output center
for defense reactions, certain structures of the midbrain tectum
may also be involved in processing aversive information [45,9].
For example, aversive stimulation of the IC at the escape threshold
Fig. 2. (A) Dopamine levels in the basolateral amygdala during conditioned fear. Extracellular levels of dopamine (DA) in the BLA in rats that were previously subjected to
paired (conditioned) or unpaired (control) exposure to light and footshock and exposed to the light-CS in the fear conditioning test. (Inset) Conditioned freezing behavior
during the 20 min period of the light-CS test session without footshock. #P < 0.05, different from baseline (60, 30, and 0 min); ⁄P < 0.05, different from control group
(Newman–Keuls post hoc test). Arrows indicate the start and end of the conditioned fear test. (B) Effects of injections of the D2 receptor antagonist sulpiride in the basolateral
amygdala on fear conditioning (fear-potentiated startle). The ﬁgure shows the mean startle amplitude in rats that were treated with sulpiride (1.0 and 2.0 lg/0.2 ll) before
the test session. #P < 0.05, compared with noise-alone; ⁄P < 0.05, compared with light-noise in the saline group (Newman–Keuls test). (C) Effects of intra-inferior colliculus
(IC) injections of vehicle or 2.0 and 3.0 lg/0.2 ll sulpiride on the amplitude of auditory-evoked potentials recorded in the IC in response to presentations of a loud noise.
⁄P < 0.05, compared with control group (Newman–Keuls test). (D) Effects of intra-IC injections of vehicle or 1.0, 2.0, and 4.0 lg/0.2 ll sulpiride/0.2 ll on exploratory behavior
in rats in the elevated plus maze. The ﬁgure shows the number of entries into the closed and open arms. ⁄P < 0.05, compared with control group (Newman–Keuls test). Further
details can be found in De Oliveira et al. [20,22] and Muthuraju et al. [35].
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intracollicular injections of the non-selective dopamine receptor
antagonist haloperidol enhanced auditory-evoked potentials
(AEPs) that were recorded directly from the IC in rats that were
subjected to loud sounds as the US [35]. These results support pre-
vious studies from our laboratory that showed that systemic injec-
tions of sulpiride enhanced escape responses in rats that in the
switch-off procedure [36] and increased the frequency of ultra-
sonic vocalizations during the training sessions in a fear condition-
ing test [14]. These data are in sharp contrast to other studies on
the association between enhanced dopamine transmission and
conditioned fear. For example, such studies reported that intra-
amygdala injections of sulpiride attenuated the expression of con-
ditioned fear [18,19,20,21,22]. We thus hypothesize a dual role for
dopamine in defensive behavior that may explain some of these
conﬂicting results.
4. Integrated view
In an attempt to integrate the above ﬁndings, we propose the
following. The neurobiological function of dopamine in anxiety
has been investigated in several laboratories. The current generalidea is that the activation of dopamine pathways that arise from
the VTA increases learned anxiety. The functional role of dopamine
pathways that connect the VTA to the BLA in the mediation of con-
ditioned fear/anxiety has been suggested by many studies from
several laboratories [3,34,40,41,46,31,1,23]. In one of these studies
from our laboratory [20], in vivo microdialysis was performed to
measure dopamine levels in the BLA in Wistar rats that were sub-
jected to footshock (US) that was associated with a neutral stimu-
lus (CS). When these rats were exposed to the CS alone without
footshock, freezing was the most prominent behavioral response,
accompanied by the signiﬁcant release of dopamine in the BLA
(Fig. 2A, arrows). In this study, fear-potentiated startle (i.e., a com-
mon conditioning model of anxiety in animals) was used to assess
the way in which dopamine mechanisms are activated during con-
ditioned fear. The animals were subjected to the pairing of
light + footshock. The next day, they were subjected to a session
that consisted of 60 trials, half with loud noise and half with loud
noise + light (CS). Fear-potentiated startle was evident when star-
tle in response to light + noise was higher than to noise alone.
The difference between the magnitude of the startle response
under both conditions reﬂects the state of conditioned fear of the
animals and has been utilized as a reliable measure of anxiety in
Fig. 3. Schematic diagram that shows the generation and organization of conditioned and unconditioned fear responses in response to respective conditioned and
unconditioned stimuli that target the mesocorticolimbic system and encephalic aversion system, respectively. Hormonal factors may inhibit ð>Þ or activate (?) defense
reactions. VTA, ventral tegmental area. Dopamine has opposite actions on these systems (+, ).
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attenuated fear-potentiated startle, indicating that D2 receptors
in this amygdaloid nucleus mediate conditioned fear responses
(Fig. 2B). Thus, these data support the hypothesis that dopamine
may plan an anxiogenic role in rostral brain structures, such as
the hippocampus, amygdala, and prefrontal cortex, which are acti-
vated by CSs.
As mentioned above, the EAS is amultifaceted neural circuit that
involves several neurotransmitters (GABA, serotonin, excitatory
amino acids, and neurokinins, among others) and plays a role in
modulating the organization, elaboration, and expression of
defense reactions. However, the use of tests of unconditioned fear
has generated experimental results that do not always ﬁt the
hypothesis of dopamine’s anxiogenic role [36,14,22,35]. Studies
that used aversive USs that decisively activate brainstem struc-
tures, such as the IC, to elicit defensive behavior in rats has led to
the suggestion that dopamine exerts an antiaversive action in this
brain region [35,22]. Thus, the ascending dopamine pathway that
originates in the VTA and innervates the amygdala and frontal cor-
tex has been suggested to facilitate conditioned fear, whereas the
periventricular pathway that innervates the dPAG and IC inhibits
innate ﬁght/ﬂight reactions to impending danger. These latter stud-
ies showed, in contrast to animal models of anxiety, that D2 recep-
tor antagonism at the level of the midbrain tectum in rats that are
exposed to unconditioned aversive stimuli increases defensive
reactions in the elevated plus maze and in response to the pre-
sentation of repetitive loud noises (100 dB). Indeed, sulpiride injec-
tions in the IC increased AEPs that were recorded directly from
electrodes implanted in the IC during the presentation of repetitive
loud noise (Fig. 2C) and enhanced avoidance of the height and open-
ness of the open arms of the elevated plus maze (Fig. 2D).
Supporting these results, a substantial concentration of dopamine
has been found in the midbrain tectum, particularly in the IC [29].
We also showed that the same pattern of responses emerged when
sulpiride was injected into deep layers of the superior colliculus.
Sulpiride injections in the dPAG caused proaversive effects in rats
in the elevated plus maze (manuscript in preparation).
Altogether, the extant evidence suggests that the activation of
dopamine pathways that arise from the VTA increases learnedanxiety, with possibly an opposite action on innate fear. The results
support our hypothesis of a dual role of dopamine-mediated
mechanisms in unconditioned and conditioned fear and that these
different responses to aversive stimuli can be neurally dissociated
from each other. This new approach to associating dopaminergic
mechanisms with anxiety has led to some intriguing questions.
Benzodiazepine anxiolytics supposedly decrease dopamine release
in the frontal cortex [24,25], and neuroleptics that are known for
their ability to decrease dopamine neurotransmission in limbic
structures exert antipsychotic rather than anxiolytic effects. The
proposal presented herein opens a window on further discussions
on the implications of dopamine’s mediation of the multiple facets
of anxiety disorders.
5. Concluding remarks
The present review provides evidence of the opposing actions of
dopamine-mediated mechanisms in fear/anxiety processes.
Depending on the type of threatening condition (i.e., conditioned
or unconditioned), dopamine D2 receptor antagonists may reduce
or heighten the aversiveness of the situation. Intra-BLA injections
of these compounds clearly reduce conditioned fear in rats that
are subjected to animal models of anxiety [20,21,14,23]. To test
the hypothesis that dopamine plays a modulatory role in the neu-
ral substrates of fear in periventricular structures, we microin-
jected dopamine receptor antagonists into the IC to inhibit D2
receptor-mediated mechanisms. This treatment impaired explora-
tory behavior in rats in the elevated plus maze and enhanced AEPs
that were recorded in the IC in response to loud sounds [35,22].
Thus, dopamine appears to mediate conditioned fear by acting at
rostral levels of the brain, and dopamine in midbrain areas appears
to regulate unconditioned fear, likely by reducing the sensorimotor
gating of aversive events. Thus, the reduction of dopamine activity
enhances unconditioned fear, likely by acting at the midbrain level,
opening sensory gating for aversive events, and reducing condi-
tioned fear by acting at more rostral levels of the brain (Fig. 3).
Further studies are needed to clarify the differential roles of dopa-
mine in conditioned and unconditioned fear to shed more light on
the neurobiological complexity of mental disorders.
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